Purpose: To establish a simple and accurate photodynamic diagnosis (PDD) method for oral squamous cell carcinoma (OSCC). Methods: OSCC cell lines HSC-2, HSC-3, HSC-4, and Sa3, and normal human oral keratinocytes (HOK) were used. First, we examined the amount of cells needed to detect differences in fluorescence intensities for PDD. OSCC cell lines were adjusted to concentrations of 1 × 104 (104), 1 × 105 (105), and 1 × 106 (106) cells/ml. The experimental groups comprised a group with 5-aminolevulinic acid (5-ALA (+)), and a group without 5-ALA (5-ALA (-)). For each OSCC cell line, 100 μl of each concentration of cells of the 5-ALA groups was seeded onto fluorescence plates, and fluorescence intensity was measured at 60-min intervals for 240 min. Results are expressed as the ratio of fluorescence intensity in 5-ALA (+) to 5-ALA (-). As cells at the concentration of 106 cells/ml provided the clearest results, fluorescence intensities of all cell lines were measured using this concentration at 20-min intervals for 700 min using the same methods. Results: The 5-ALA (+) to (-) ratio increased in a cell concentration-dependent manner at 240 min; the ratio was highest with 106 cells/ml and lowest with 104 cells/ml. With 106 cells/ml in the 5-ALA (+) group, fluorescence intensity increased in a metabolic time-dependent manner; the increase was highest in HSC-2 cells, followed by HSC-4 cells, HSC-3 cells, Sa3 cells, and HOK. Fluorescence intensity was significantly enhanced after 40 min in HSC-2, HSC-3, and HSC-4 cells, after 60 min in Sa3 cells, and after 100 min in HOK compared to the 5-ALA (-) group (P < 0.05). Moreover, fluorescence intensity was significantly increased in OSCC cell lines compared to HOK after 40 min. Conclusion: Early detection of OSCC is possible by screening only microplate reader measurements of fluorescence intensity for PDD.
References
[1]
Ministry of Health, Labour and Welfare (2020) 2019 Summary of Vital Statistics. Ministry of Health, Labour and Welfare. https://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei19/index.html
[2]
Nobuharu, Y., Kazumichi, S., Tomohiro, Y., Taiki, S., Ryuta, O., Mira, K., Yoshifumi, Y., Sunaki, N., Ken, I., Masayuki, T., Akira, K., Yoichi, T., Takahiko, S. and Nobuo, T. (2013) A 5-Year Activity Report from the Oral Cancer Center, Tokyo Dental College. The Bulletin of Tokyo Dental College, 54, 265-273. https://doi.org/10.2209/tdcpublication.54.265
[3]
Takuro, K., Mika, S., Kanae, A., Noriko, O., Yasuyuki, M., Sakae, H. and Mitsuyoshi, H. (1997) Examination of Oversights in Screening. The Journal of the Japanese Society of Clinical Cytology, 36, 136-140. https://doi.org/10.5795/jjscc.36.136
[4]
Masami, S., Mitsutoshi, S., Yasuki, S., Yukitoshi, S., Kiyoshi, S., Takaaki, T., Tomio, N., Takeshi, H., Norihiko, I., Ei, K., Hiroyuki, M., Ryutaro, N., Akemi, T., Kazunobu, Y., Nikako, S., Junko, K., Midori, N., Shinji, M., Yukihiro, S., Ryota, T. and Chiaki, E. (2015) Inter-Rater Agreement of Sputum Cytology for Lung Cancer Screening in Japan. The Japan Lung Cancer Society, 55, 859-865. https://doi.org/10.2482/haigan.55.859
[5]
Akira, F., Kayo, K., Mana, F. and Masahiko, F. (2015) Comparison of Liquid-Based Cytology and Conventional Cytology in Squamous Cell Carcinoma. Journal of the Japan Academy of Oral Human Dock, 10, 41-48.
[6]
Keiji, I., Hideo, F. and Taro, S. (2015) TURBT Assisted by Photodynamic Diagnosis Using Aminolevulinic Acid. Japanese Journal of Endourology, 28, 187-191.
[7]
Masafumi, O. (2014) Photodynamic Diagnosis Using 5-Aminolevulinic Acid: A Clinical Approach to Urologic Tumors. Journal of Saitama Medical University, 41, 7-13.
[8]
Hajime, I., Kumi, O., Takemasa, S., Ken, O., Naoyuki, Y., Kazuhiko, N. and Atsushi, N. (2015) 5-Aminolevulinic Acid Mediated Photodynamic Diagnosis with a Laser-Equipped Video Image Endoscope. The Japanese Language Society of Malaysia, 36, 113-118. https://doi.org/10.2530/jslsm.jslsm-36_0016
[9]
Yoshinori, H. (2013) Fluorescence Diagnosis of Lymph Node Metastasis of Gastrointestinal Cancers by Using 5-Aminolevulinic Acid (5-ALA). Journal of Kyoto Prefectural University of Medicine, 122, 181-188.
[10]
Jiro, A. (2016) Photodynamic Therapy for Malignant Brain Tumors. Neurologia Medico-Chirurgica, 56, 151-157. https://doi.org/10.2176/nmc.ra.2015-0296
[11]
Masanao, Y., Hirohumi, F., Naoki, K., Keiji, I., Hitoshi, N., Kozo, U., Junzo, S. and Hideyo, O. (2013) Improvement of the Efficacy of 5-Aminolevulinic Acid-Mediated Photodynamic Treatment in Human Oral Squamous Cell Carcinoma HSC-4. Acta Medica (Okayama), 67, 153-164.
[12]
Masaru, U., Ken, O., Yusuke, N., Shogo, H., Hiroyuki, H., Keiichi, M. and Hitoshi, T. (2010) Uptake and Kinetics of 5-Aminolevulinic Acid in Oral Squamous Cell Carcinoma. International Journal of Oral and Maxillofacial Surgery, 39, 802-805. https://doi.org/10.1016/j.ijom.2009.11.024
[13]
Qian, P., Trond, W., Kristian, B., Johan, M., Magne, K., Karl-Erik, G. and Jahn, M.N. (1997) 5-Aminolevulinic Acid-Based Photodynamic Therapy: Clinical Research and Future Challenges. Cancer, 15, 2282-2308. https://doi.org/10.1002/(SICI)1097-0142(19970615)79:12<2282::AID-CNCR2>3.0.CO;2-O
[14]
Shigeru, T., Yasushi, A. and Yoshitsugu, N. (2000) Regulation of the Expression of Human Ferrochelatase by Intracellular Iron Levels. The FEBS Journal, 267, 4685-4692. https://doi.org/10.1046/j.1432-1327.2000.01519.x
[15]
Fumio, M., Shouji, H., Toshio, A., Nobuyuki, T. and Shigetoshi, S. (1986) Characterization of Three Oral Squamous Cell Carcinoma-Derived Cells. Journal of the Japanese Stomatological Society, 35, 485-496.
[16]
Masakazu, H., Kazuyuki, M., Takeshi, W., Tetsuji, O., Nobuo, M. and Tadayuki, S. (1993) Establishment and Characterization of a cell Line (Sa3) from Squamous Cell Carcinoma of the Human Gingiva. Journal of the Japanese Stomatological Society, 39, 965-971.
[17]
Tomoyuki, H., Youhei, M., Fumihiro, H., Kanchu, T. and Motoaki, Y. (2020) ELAVL2 Expression in Oral Squamous-Cell Carcinoma cell Lines. Hokkaido Journal of Dental Science, 40, 79-86.
[18]
Kazumasa, M., Yusuke, A., Hiroko, K., Tetsuya, T., Ryo, K. and Michio, A. (2018) TRKB Tyrosine Kinase Receptor Is a Potential Therapeutic Target for Poorly Differentiated Oral Squamous Cell Carcinoma. Oncotarget, 9, 25225-25243. https://doi.org/10.18632/oncotarget.25396
[19]
Masaru, U. (2009) Fluorescence Analysis of Oral Squamous Cell Carcinoma with 5-Aminolevulinic Acid Labeling. The Journal of the Stomatological Society, Japan, 76, 31-36.
[20]
Petras, J., Asta, J. and Johan, M. (2005) Deferoxamine Photosensitizes Cancer Cells in Vitro. Biochemical and Biophysical Research Communications, 332, 388-391. https://doi.org/10.1016/j.bbrc.2005.04.138
[21]
Pablo, A.V., Kimberley, S., O’Hara, J.A., Roberts, D.W., Paulsen, K.D. and Pogue, B.W. (2010) Deferoxamine Iron Chelation Increases δ-Aminolevulinic Acid Induced Protoporphyrin IX in Xenograft Glioma Model. Journal of Photochemistry and Photobiology, 86, 471-475. https://doi.org/10.1111/j.1751-1097.2009.00664.x
[22]
Yang, J.B., Xia, Y.M., Liu, X.M., Jiang, S. and Xiong, L.Y. (2010) Desferrioxamine Shows Different Potentials for Enhancing 5-Aminolevulinic Acid-Based Photodynamic Therapy in Several Cutaneous Cell Lines. Lasers in Medical Science, 25, 251-257. https://doi.org/10.1007/s10103-009-0721-0
[23]
Kitajima, Y., Ishii, T., Kohda, T., Ishizuka, M., Yamazaki, K., Nishimura, Y., Tanaka, T., Dan, S. and Nakajima, M. (2019) Mechanistic Study of PpIX Accumulation Using the JFCR39 Cell Panel Revealed a Role for Dynamin 2-Mediated Exocytosis. Scientific Reports, 9, Article No. 8666. https://doi.org/10.1038/s41598-019-44981-y
